title: SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
abstract: Lung cancer is the most common cancer worldwide as well as the leading cause of cancer related deaths as reported by Torre et al (CA Cancer J Clin 65:87-108, 2015]. Non-small cell lung cancer (NSCLC) accounts for up to 85 % of all lung cancers. Multiple advances in the staging, diagnostic procedures, therapeutic options, as well as molecular knowledge have been achieved during the past years, although the overall outlook has not greatly changed for the majority of patients with the overall 5-year survival having marginally increased over the last decade from 15.7 to 17.4 % as reported by Howlader et al. (SEER Cancer Statistics Review 2015).
authors.affiliation: Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Coruña, Spain. maria.rosario.garcia.campelo@sergas.es.
authors.forename: R
authors.initials: R
authors.lastname: García-Campelo
authors.affiliation: Medical Oncology Department, Hospital Universitario Nstra. Sra. de Valme, Seville, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Bernabé
authors.affiliation: Medical Oncology Department, Hospital Universitario Málaga, Málaga, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Cobo
authors.affiliation: Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Corral
authors.affiliation: Medical Oncology Department, Hospital Son Llatzer, Palma De Mallorca, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Coves
authors.affiliation: Hospital Universitario Fundación Jiménez Díaz. Oncohealth Institute, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Dómine
authors.affiliation: Medical Oncology Department, Instituto Catalán de Oncología, L'Hospitalet, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Nadal
authors.affiliation: Medical Oncology Department, Hospital Universitario Insular de Las Palmas de Gran Canaria, Las Palmas, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Rodriguez-Abreu
authors.affiliation: Medical Oncology Department, Hospital Clinic I Provincial de Barcelona, Barcelona, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Viñolas
authors.affiliation: Medical Oncology Department, Hospital General Universitario Alicante, Alicante, Spain.
authors.forename: B
authors.initials: B
authors.lastname: Massuti
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D019468:Disease Management; D055088:Early Detection of Cancer; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D008495:Medical Oncology; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic / Q000592:standards*; D011379:Prognosis; D012955:Societies, Medical
keywords: Chemotherapy; NSCLC; Radiotherapy; Targeted therapies